High-Risk Newborn: Acquired and Congenital Conditions

Congenital and acquired conditions are high-risk complications requiring prompt recognition and intervention. Congenital conditions refer to genetic disorders or physical anomalies that occur during fetal development, such as phenylketonuria, cleft palate, and cardiac defects.

On the other hand, acquired conditions occur postnatally, meaning at or shortly after birth, and include pathologic jaundice, sepsis neonatorum, and meconium aspiration syndrome.Okay, so jaundice, also known as hyperbilirubinemia, is a condition caused by the build-up of a yellow pigment called bilirubin, that’s produced in the liver by breaking down hemoglobin from red blood cells.

Most newborns develop mild hyperbilirubinemia, called physiologic jaundice, which is a self-limiting condition that requires no treatment.On the other hand, pathologic jaundice, sometimes called non-physiologic jaundice, is a more severe form of jaundice, that is most commonly caused by excessive hemolysis, or red blood cell destruction, leading to an excessive build-up of bilirubin in the blood.

Risk factors for excessive hemolysis include incompatibility between the maternal and fetal ABO and Rh blood types; polycythemia, or an excessive amount of circulating red blood cells; or the presence of extravascular blood, like bruising or cephalohematoma from birth trauma.

Other risk factors include sepsis and liver impairment.Without proper treatment, pathologic jaundice can lead to acute bilirubin encephalopathy, where bilirubin crosses the blood-brain barrier, deposits in the brain, and causes impaired neurologic function.

This can progress to kernicterus, or chronic bilirubin encephalopathy, which is irreversible neurological damage, resulting in long-term effects like cerebral palsy and hearing loss.

Clinical manifestations of pathologic jaundice include a rapid rise in bilirubin within the first 24 hours of life that persists at an elevated level longer than expected.

The newborn may have yellow-tinged sclera and mucous membranes; and in newborns with lighter skin, yellow or orange-tinged skin is often present.

In newborns with darker skin, jaundice is often better visualized in the palms of the hands and soles of the feet.Now, diagnosis of hyperbilirubinemia involves laboratory tests like total serum bilirubin, or TSB.

The TSB can also be estimated by measuring the newborn’s transcutaneous bilirubin level, or TcB. The expected level varies with age in hours, so treatment decisions are made by plotting the level on an hour-specific graph, such as the BiliTool.

Treatment includes phototherapy, where the newborn is placed under phototherapy lights or wrapped in a fiberoptic phototherapy blanket.

The bilirubin in the skin then absorbs the light and becomes water soluble so it can be excreted through urine and stool.

In severe cases, blood exchange transfusions are needed to reduce excess bilirubin.Moving on to sepsis neonatorum, this is a systemic bacterial, viral, or fungal infection that develops from an infection acquired before, during, or after birth.

Since the newborn’s immune system is underdeveloped, they are highly susceptible to infections. Sepsis neonatorum can be categorized as early onset sepsis when it’s transmitted to a fetus in utero and signs and symptoms appear within the first 3 days after delivery.

It's typically caused by prolonged rupture of membranes and chorioamnionitis, which is an infection of the placenta and amniotic fluid.

On the other hand, late onset sepsis is transmitted to a newborn during or after birth, with signs and symptoms appearing after the first week of life.

It can be caused by pathogens transferred during passage through the birth canal, from hospital-acquired infections, or ill family members or visitors.Clinical manifestations of sepsis neonatorum include temperature instability; respiratory distress, including tachypnea, apnea, nasal flaring, retractions, and grunting; cardiovascular changes, like bradycardia, tachycardia, and hypotension; cyanosis or skin mottling; feeding difficulties; as well as irritability, lethargy, and jaundice.Diagnosis is made by physical exam and laboratory testing and may include decreased total neutrophil count along with increased bands, or immature neutrophils; and elevated inflammatory markers like procalcitonin and C-reactive protein, or CRP.

Treatment typically includes antimicrobials, supplemental oxygen, and IV fluids.Next, meconium aspiration syndrome, or MAS, occurs when meconium, or the thick, sticky, green-black stool that forms during gestation, is released into the amniotic fluid and enters the lungs, causing complications such as chemical pneumonitis, occlusion of the airways, and alveolar collapse.

Passage of meconium in utero typically occurs when fetal hypoxia stimulates intestinal peristalsis and relaxation of the anal sphincter, allowing meconium to pass into the amniotic fluid.

From there, the fetus either aspirates the meconium during gasping movements or when taking its first breaths following birth.Risk factors for developing MAS include conditions that cause intrauterine hypoxia and distress, such as placental insufficiency and umbilical cord compression.

Additionally, the risk of MAS increases in preterm birth, or birth before 37 weeks of gestation, and post-term birth, or birth after 42 weeks of gestation.Diagnosis of MAS is made based on the presence of meconium-stained amniotic fluid at birth and is confirmed with a chest X-ray.

Since symptoms can range from mild to severe, treatment varies and can include surfactant therapy; respiratory support with supplemental oxygen, continuous positive airway pressure, or CPAP, and mechanical ventilation; or extra-corporeal membrane oxygenation, or ECMO.Alright, as a quick recap...High-risk newborn conditions can be acquired or congenital.

Acquired conditions include pathologic jaundice, sepsis neonatorum, and meconium aspiration syndrome. based on the presence of meconium stained amniotic fluid at birth and is confirmed with a chest x-ray Since symptoms can range from mild to severe treatment varies and can include surfactant therapy respiratory support with supplemental oxygen continuous positive airway pressure or CPAP and mechanical ventilation or extracorporeal membrane oxygenation or ECMO All right as a quick recap high-risk newborn conditions can be acquired or congenital Acquired conditions include pathologic jaundice